The Daily Californian covers the city of Berkeley and the campus in unparalleled detail, all while training the future of the journalism industry. Consider making a donation to support the coverage that shapes the face of Berkeley.
Last week, the University of California filed an opening brief to appeal a decision by the U.S. Patent Trial and Appeal Board (PTAB) which denied UC patent claims for CRISPR-Cas9 technology in eukaryotic cells.
Read More…
Researchers at UC Berkeley and UC Riverside have merged computational and molecular biology to demonstrate the potential that gene modification may have in suppressing mosquito-borne infectious diseases.
Read More…
The U.S. Patent and Trademark Office agreed Monday to decide whether a UC Berkeley research team will be awarded the rights to the groundbreaking CRISPR-Cas9 technology, which could be worth billions of dollars and serve as the foundation for the burgeoning field of gene editing.
Read More…
